Arimidex 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6SG3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,452
Award facts
- Contract value 100% obligated
- $37,452.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $37,452.21 to Amerisourcebergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of January 16, 2026, represents a non-set-aside, competitively awarded contract executed under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate headquarters. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is registered in the System for Award Management and serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems.
This award demonstrates the ongoing pharmaceutical supply partnership between the Defense Logistics Agency and Amerisourcebergen for medical commodities supporting military treatment facilities and government healthcare programs. Arimidex, an aromatase inhibitor used in cancer treatment, represents one of numerous specialty medications delivered through the company's comprehensive pharmaceutical prime vendor agreement with DLA. The delivery order structure provides the government with efficient access to essential oncology medications while maintaining firm pricing terms for budget predictability.
Quick answers
Who was awarded contract SPE2DR26F6SG3?
SPE2DR26F6SG3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F6SG3 worth?
The government has obligated $37,452 on SPE2DR26F6SG3.
Is contract SPE2DR26F6SG3 an order under another contract?
Yes. SPE2DR26F6SG3 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6SG3 competed?
The extent of competition for SPE2DR26F6SG3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award